To assess oxidant stress responses in newborn infants treated with ele
vated concentrations of oxygen, we measured plasma concentrations of g
lutathione (GSH) and glutathione disulfide (GSSG) in newborn infants r
anging from 23 to 42 wk gestational age. All infants recruited into th
e study were mechanically ventilated and had catheters placed in their
umbilical arteries as part of their normal clinical management. Blood
samples were obtained on d 1, 3, and 5 and weekly thereafter or until
the catheters were removed. We observed plasma concentrations of GSSG
in these infants that were frequently an order of magnitude higher th
an the 0.1 to 0.3 muM we find in adults. Interestingly, plasma GSSG co
ncentrations were inversely correlated to the inspired oxygen tensions
. This effect appeared to arise from the patient selection criteria wh
ereby, of the infants studied, those breathing the lowest partial pres
sures of oxygen were the smallest and gestationally youngest. A second
observation was that plasma concentrations of GSH in the premature in
fants were substantially, indeed often dramatically, lower than we hav
e observed in adult humans (6 to 10 muM). Finally, we found that in pa
tients with both umbilical arterial and umbilical venous catheters art
erial GSSG concentrations were consistently higher than venous concent
rations; conversely, arterial GSH concentrations were lower than venou
s concentrations. The elevated GSSG concentrations we observed in thes
e infants indicate marked oxidant stress responses in prematurely born
infants, even in those infants exposed only to room air. The positive
arteriovenous gradients of GSSG concentrations across the lungs of th
ese infants suggest that at least some of the increased plasma GSSG or
iginates in the lung. The low plasma GSH concentrations we observed in
these same infants suggest deficiencies in an antioxidant that has be
en shown in numerous animal studies to be critical for prevention of h
yperoxia-induced lung injury. Finally, the negative arteriovenous grad
ients of GSH concentrations across the lung provide the first evidence
in humans for pulmonary uptake of GSH.